A new analysis has uncovered a potential link between higher prostate cancer risk and genetic variants associated with higher bloodstream levels of the cholesterol-transporting molecule lipoprotein A. Anna Ioannidou of Imperial ...
Jan 27, 2022
0
59
Researchers at Karolinska Institutet in Sweden have together with international collaborators completed a comprehensive international validation of artificial intelligence (AI) for diagnosing and grading prostate cancer. ...
Jan 13, 2022
0
89
A molecular feature in prostate cancer, called endogenous retroviral (ERV) RNA, has been found to have prognostic value and also distinguish differences between men of African and European or Middle Eastern ancestry, according ...
Jan 13, 2022
0
26
UCLA Jonsson Comprehensive Cancer Center researchers leading a meta-analysis of seven randomized trials found an "unexpected result": Although Black men appeared to have more aggressive disease when they enrolled in clinical ...
Dec 29, 2021
1
72
While researchers have identified several genes that drive prostate cancer, a new study published in Nature reveals the puppet master controlling the strings.
Dec 27, 2021
0
44
Cold Spring Harbor Laboratory (CSHL) Associate Professor Pavel Osten and Professor Lloyd Trotman have developed a new way to study the life history of prostate cancer in mice. The pair combined their expertise in whole-organ ...
Nov 16, 2021
0
26
Men who inherit an increased risk of cancer through "Lynch syndrome" could benefit from regular PSA testing from age 40 to detect early signs of prostate cancer, researchers believe.
Oct 19, 2021
0
57
Common gut bacteria can fuel the growth of prostate cancers and allow them to evade the effects of treatment, a new study finds.
Oct 7, 2021
0
133
The international team led by Dr. Jacqui McGovern, from the Centre for Biomedical Technologies, used tissue engineering and regenerative medicine principles to create primary tumors with their microenvironment and humanized ...
Sep 28, 2021
0
46
When treating a cancer patient, oncologists aim to predict the course of the patient's disease to make critical treatment decisions. Knowing a tumor's unique molecular signature can help guide these decisions by providing ...
Sep 23, 2021
0
75
